Figure 6 | Scientific Reports

Figure 6

From: Enhancing bioactivity, physicochemical, and pharmacokinetic properties of a nano-sized, anti-VEGFR2 Adnectin, through PASylation technology

Figure 6

Toxicity assessment of Adnectin C, and Adnectin C-PAS#1(200) on HUVECs in culture (a), inhibition of VEGF-induced cell proliferation in HUVECs by recombinant proteins (b), and a schematic representation for mechanism of action of Adnectin C-PAS#1(200) (c). The data are represented as mean ± SD (three replicates). Asterisks show the significance of survival rate of samples versus VEGF group (****p < 0.0001).

Back to article page